Boston, United States
Cellular Intelligence is an AI-native TechBio company on the cutting edge of biotechnology and artificial intelligence integration. They are developing the first universal virtual cell-signaling model with the potential to revolutionize the understanding and manipulation of cellular communication.
The company's proprietary capsule technology significantly enhances the efficiency of generating dynamic cellular data—by over 1,000x compared to existing methods. This breakthrough capability enables Cellular Intelligence to train large-scale predictive models. These models have expansive applications, including designing and optimizing protocols for regenerative medicine, predicting drug responses, and modeling disease mechanisms.
Headquartered in Boston and founded by top-tier AI entrepreneurs and scientific experts, the company has attracted substantial financial backing, raising more than $62 million from renowned investors such as Khosla Ventures and the Chan Zuckerberg Initiative. With its impressive technological advances and robust investor support, Cellular Intelligence is poised to drive significant advancements in the field of human health.
